Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.

NCT01835678 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Type 2-diabetes

Interventions

DRUG: Linagliptin
DRUG: Placebo

Sponsor

University of Erlangen-Nürnberg Medical School